234 related articles for article (PubMed ID: 8151377)
1. Significance of defect severity in technetium-99m-MIBI SPECT at rest to assess myocardial viability: comparison with fluorine-18-FDG PET.
Altehoefer C; vom Dahl J; Biedermann M; Uebis R; Beilin I; Sheehan F; Hanrath P; Buell U
J Nucl Med; 1994 Apr; 35(4):569-74. PubMed ID: 8151377
[TBL] [Abstract][Full Text] [Related]
2. Fluorine-18 deoxyglucose PET for assessment of viable myocardium in perfusion defects in 99mTc-MIBI SPET: a comparative study in patients with coronary artery disease.
Altehoefer C; Kaiser HJ; Dörr R; Feinendegen C; Beilin I; Uebis R; Buell U
Eur J Nucl Med; 1992; 19(5):334-42. PubMed ID: 1612095
[TBL] [Abstract][Full Text] [Related]
3. Rest distribution of 99mTc-MIBI in patients with coronary artery disease assessed by SPECT: comparison with the distribution of [18F]FDG assessed by PET.
Gang H; Lucignani G; Landoni C; Galli L; Vanoli G; Rossetti C; Paganelli G; Fazio F
J Nucl Biol Med (1991); 1994 Dec; 38(4):540-4. PubMed ID: 7786915
[TBL] [Abstract][Full Text] [Related]
4. [Comparison of relative 18FDG uptake with metabolic rate (MRGlucose) in the myocardium in CAD, classified by 99m-Tc-MIBI].
Büll U; Foroutan Y; Hellwig D; Kaiser HJ; Schulz G; Sabri O; Schreckenberger M; vom Dahl J
Nuklearmedizin; 1995 Dec; 34(6):223-8. PubMed ID: 8596738
[TBL] [Abstract][Full Text] [Related]
5. Assessment of myocardial perfusion and viability with technetium-99m methoxyisobutylisonitrile and thallium-201 rest redistribution in chronic coronary artery disease.
Rossetti C; Landoni C; Lucignani G; Huang G; Bartorelli AL; Guazzi MD; Margonato A; Chierchia S; Galli L; Savi A
Eur J Nucl Med; 1995 Nov; 22(11):1306-12. PubMed ID: 8575482
[TBL] [Abstract][Full Text] [Related]
6. Comparison of sestamibi single-photon emission computed tomography with positron emission tomography for estimating left ventricular myocardial viability.
Soufer R; Dey HM; Ng CK; Zaret BL
Am J Cardiol; 1995 Jun; 75(17):1214-9. PubMed ID: 7778542
[TBL] [Abstract][Full Text] [Related]
7. [Assessing myocardial viability in chronic myocardial infarct with 18F-fluoro-D-glucose positron emission tomography and 99mTc-MIBI SPECT].
Schneider CA; Voth E; Theissen P; Wienhard K; Wagner R; Baer FM; Sechtem U; Schicha H
Z Kardiol; 1994 Feb; 83(2):124-31. PubMed ID: 8165842
[TBL] [Abstract][Full Text] [Related]
8. Assessment of myocardial viability in chronic coronary artery disease using technetium-99m sestamibi SPECT. Correlation with histologic and positron emission tomographic studies and functional follow-up.
Maes AF; Borgers M; Flameng W; Nuyts JL; van de Werf F; Ausma JJ; Sergeant P; Mortelmans LA
J Am Coll Cardiol; 1997 Jan; 29(1):62-8. PubMed ID: 8996296
[TBL] [Abstract][Full Text] [Related]
9. Rest myocardial perfusion/metabolism imaging using simultaneous dual-isotope acquisition SPECT with technetium-99m-MIBI/fluorine-18-FDG.
Delbeke D; Videlefsky S; Patton JA; Campbell MG; Martin WH; Ohana I; Sandler MP
J Nucl Med; 1995 Nov; 36(11):2110-9. PubMed ID: 7472607
[TBL] [Abstract][Full Text] [Related]
10. Comparison of 99mTc-sestamibi-18F-fluorodeoxyglucose dual isotope simultaneous acquisition and rest-stress 99mTc-sestamibi single photon emission computed tomography for the assessment of myocardial viability.
De Boer J; Slart RH; Blanksma PK; Willemsen AT; Jager PL; Paans AM; Vaalburg W; Piers DA
Nucl Med Commun; 2003 Mar; 24(3):251-7. PubMed ID: 12612465
[TBL] [Abstract][Full Text] [Related]
11. Evaluation of myocardial ischemia using a rest metabolism/stress perfusion protocol with fluorine-18 deoxyglucose/technetium-99m MIBI and dual-isotope simultaneous-acquisition single-photon emission computed tomography.
Sandler MP; Videlefsky S; Delbeke D; Patton JA; Meyerowitz C; Martin WH; Ohana I
J Am Coll Cardiol; 1995 Oct; 26(4):870-8. PubMed ID: 7560611
[TBL] [Abstract][Full Text] [Related]
12. Effect of myocardial viability assessed by technetium-99m-sestamibi SPECT and fluorine-18-FDG PET on clinical outcome in coronary artery disease.
vom Dahl J; Altehoefer C; Sheehan FH; Buechin P; Schulz G; Schwarz ER; Koch KC; Uebis R; Messmer BJ; Buell U; Hanrath P
J Nucl Med; 1997 May; 38(5):742-8. PubMed ID: 9170439
[TBL] [Abstract][Full Text] [Related]
13. Enhanced detection of viable myocardium by technetium-99m-MIBI imaging after nitrate administration in chronic coronary artery disease.
Maurea S; Cuocolo A; Soricelli A; Castelli L; Nappi A; Squame F; Imbriaco M; Trimarco B; Salvatore M
J Nucl Med; 1995 Nov; 36(11):1945-52. PubMed ID: 7472580
[TBL] [Abstract][Full Text] [Related]
14. Myocardial viability in patients with chronic coronary artery disease. Comparison of 99mTc-sestamibi with thallium reinjection and [18F]fluorodeoxyglucose.
Dilsizian V; Arrighi JA; Diodati JG; Quyyumi AA; Alavi K; Bacharach SL; Marin-Neto JA; Katsiyiannis PT; Bonow RO
Circulation; 1994 Feb; 89(2):578-87. PubMed ID: 8313546
[TBL] [Abstract][Full Text] [Related]
15. Imaging of beta-oxidation by static PET with 14(R,S)-[18F]-fluoro-6-thiaheptadecanoic acid (FTHA) in patients with advanced coronary heart disease: a comparison with 18FDG-PET and 99Tcm-MIBI SPET.
Schulz G; von Dahl J; Kaiser HJ; Koch KC; Sabri O; Banneitz L; Cremerius U; Buell U
Nucl Med Commun; 1996 Dec; 17(12):1057-64. PubMed ID: 9004303
[TBL] [Abstract][Full Text] [Related]
16. Myocardial metabolic imaging by means of fluorine-18 deoxyglucose/technetium-99m sestamibi dual-isotope single-photon emission tomography.
Stoll HP; Hellwig N; Alexander C; Ozbek C; Schieffer H; Oberhausen E
Eur J Nucl Med; 1994 Oct; 21(10):1085-93. PubMed ID: 7828618
[TBL] [Abstract][Full Text] [Related]
17. Myocardial viability index in chronic coronary artery disease: technetium-99m-methoxy isobutyl isonitrile redistribution.
Maurea S; Cuocolo A; Soricelli A; Castelli L; Squame F; Imbriaco M; De Luca N; Trimarco B; Salvatore M
J Nucl Med; 1995 Nov; 36(11):1953-60. PubMed ID: 7472581
[TBL] [Abstract][Full Text] [Related]
18. Comparison of thallium-201 single-photon emission tomography after rest injection and fluorodeoxyglucose positron emission tomography for assessment of myocardial viability in patients with chronic coronary artery disease.
Altehoefer C; vom Dahl J; Buell U; Uebis R; Kleinhans E; Hanrath P
Eur J Nucl Med; 1994 Jan; 21(1):37-45. PubMed ID: 8088284
[TBL] [Abstract][Full Text] [Related]
19. Positron emission tomography detects evidence of viability in rest technetium-99m sestamibi defects.
Sawada SG; Allman KC; Muzik O; Beanlands RS; Wolfe ER; Gross M; Fig L; Schwaiger M
J Am Coll Cardiol; 1994 Jan; 23(1):92-8. PubMed ID: 8277101
[TBL] [Abstract][Full Text] [Related]
20. Presurgical identification of hibernating myocardium by combined use of technetium-99m hexakis 2-methoxyisobutylisonitrile single photon emission tomography and fluorine-18 fluoro-2-deoxy-D-glucose positron emission tomography in patients with coronary artery disease.
Lucignani G; Paolini G; Landoni C; Zuccari M; Paganelli G; Galli L; Di Credico G; Vanoli G; Rossetti C; Mariani MA
Eur J Nucl Med; 1992; 19(10):874-81. PubMed ID: 1451704
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
